Главная
Study mode:
on
1
Intro
2
Evidence basis (1974-2021)
3
TRITON-38 (NEJM 2007)-Prasugrel versus Clopidogrel
4
DAPT Score (JAMA 2016)
5
Dual Antiplatelet Therapy After Complex PCI
6
Prolonged DAPT Guidelines ESC 2020
7
PRECISE-DAPT (Lancet 2017)
8
Short DAPT Meta-Analysis (EHJ 2021)
9
Short DAPT Guidelines ESC 2020
10
Types of established CAD
11
Overview (non-high bleeding risk)
12
Overview (high bleeding risk)
Description:
Learn about the latest developments and evidence-based approaches in antiplatelet therapy through a comprehensive medical lecture delivered by Dr. René Boudreau, a PGY6 Cardiology Resident at the University of Ottawa Heart Institute. Explore nearly five decades of evidence from 1974-2021, including pivotal studies like TRITON-38 and PRECISE-DAPT. Examine the evolution of dual antiplatelet therapy (DAPT) guidelines, focusing on complex PCI cases, risk stratification using the DAPT Score, and management strategies for both high and non-high bleeding risk patients. Gain practical insights into treating established coronary artery disease (CAD) and understand the latest ESC 2020 guidelines for both short and prolonged DAPT protocols.

Antiplatelet Therapy in 2022 - A Practical Review

University of Ottawa Heart Institute
Add to list
0:00 / 0:00